Steroid hormone receptors and drug discovery: Therapeutic opportunities and assay designs

被引:21
作者
Bai, C [1 ]
Schmidt, A [1 ]
Freedman, LP [1 ]
机构
[1] Merck Res Labs, Dept Mol Endocrinol, West Point, PA 19486 USA
关键词
D O I
10.1089/154065803772613471
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Steroid receptors belong to the nuclear hormone receptor superfamily, which represents one of the important families of drug targets in the pharmaceutical industry. These receptors are generally expressed in a broad range of tissues and play roles in multiple physiological pathways. They represent one of the most complex target classes for drug research as the typical pharmacologically selective, potent, and pure agonist or antagonist may not be sufficient for the development of an optimal compound for therapeutic use. In many cases, the professed compound that is a selective modulator of a steroid hormone receptor that functions as an agonist in one tissue and as an antagonist in another can offer a better therapeutic advantage. In this review, we will selectively summarize members of the steroid hormone receptor subfamily, their therapeutic opportunities, and a glimpse of the methods that can be utilized in the development of drugs that target these receptors.
引用
收藏
页码:843 / 852
页数:10
相关论文
共 68 条
  • [1] ADAMS M, 2003, IN PRESS MOL ENDOCRI
  • [2] Role of progestogen in hormone therapy for postmenopausal women: position statement of The North American Menopause Society
    不详
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2003, 10 (02): : 113 - 132
  • [3] Anthony M, 2001, ANN NY ACAD SCI, V949, P261
  • [4] CLONING OF HUMAN MINERALOCORTICOID RECEPTOR COMPLEMENTARY-DNA - STRUCTURAL AND FUNCTIONAL KINSHIP WITH THE GLUCOCORTICOID RECEPTOR
    ARRIZA, JL
    WEINBERGER, C
    CERELLI, G
    GLASER, TM
    HANDELIN, BL
    HOUSMAN, DE
    EVANS, RM
    [J]. SCIENCE, 1987, 237 (4812) : 268 - 275
  • [5] Arun Banu, 2002, Expert Opin Pharmacother, V3, P681
  • [6] Auwerx J, 1999, CELL, V97, P161
  • [7] Bai C, 1996, METHOD ENZYMOL, V273, P331
  • [8] An open label trial of C-1073 (mifepristone) for psychotic major depression
    Belanoff, JK
    Rothschild, AJ
    Cassidy, F
    DeBattista, C
    Baulieu, EE
    Schold, C
    Schatzberg, AF
    [J]. BIOLOGICAL PSYCHIATRY, 2002, 52 (05) : 386 - 392
  • [9] Rapid reversal of psychotic depression using mifepristone
    Belanoff, JK
    Flores, BH
    Kalezhan, M
    Sund, B
    Schatzberg, AF
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2001, 21 (05) : 516 - 521
  • [10] Reciprocal recruitment of DRIP/mediator and p160 coactivator complexes in vivo by estrogen receptor
    Burakov, D
    Crofts, LA
    Chang, CPB
    Freedman, LP
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (17) : 14359 - 14362